Skip to content
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
About
Our Mission
The challenge
Deliberables
Structure
Core Group
Management Committee
Working Groups
WG1: Tools for NRF2 research
WG2: Pharmacological regulation and drugs
WG3: Translational medicine
WG4. Economic Exploitation
WG5: Outreach and dissemination
Events
Scientific Meetings
Webinars
Training Schools
Open Days
Podcasts
News
Newsletters
Special Issues
Other news
Projects
Dissemination
Co-authored Action publications
Collaborative publications
Open Days
Intranet
Novel Series of Dual NRF2 Inducers and Selective MAO-B Inhibitors for the Treatment of Parkinson’s Disease
27/01/2022
Duarte P, Michalska P, Crisman E, Cuadrado A, León R
By: Duarte P, Michalska P, Crisman E, Cuadrado A, León R
Go to publication
